×
Including results for celyad investor relations
Search only for cyad investor relations
Investors · Corporate Profile · Financial Calendar · Investors Kit · Upcoming Events · Latest Financial News · Footer ...
Letter to Shareholders 2024 · Celyad Oncology reports full year 2023 financial results and recent business highlights · Celyad Oncology announces intention to ...
Missing: cyad relations
Apr 4, 2024 · Celyad Oncology, today announces its financial results for the fiscal year 2023 ended December 31, 2023, and provides a business update.
Investor Relations – Filings and financial statements from Celyad Oncology SA. Check out the latest publications, news and insider trades.
Investor and Media Contacts: Sara Zelkovic. Communications & Investor Relations Director. Celyad Oncology. investors@celyad.com. Daniel Ferry. Managing Director.
View the latest Celyad Oncology S.A. (CYAD) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Missing: relations | Show results with:relations
Largest shareholders include Eversept Partners, LP . Celyad Oncology - ADR (NASDAQ:CYAD) institutional ownership structure shows current positions in the ...
Aug 5, 2022 · ... Earnings Conference Call August 5, 2022 8:00 AM ET. Company Participants. Sara Zelkovic - Director, Communications and Investor Relations
Find the latest Celyad Oncology SA (CYAD.BR) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Financial Summary of Celyad Oncology SA(CYAD), Celyad Oncology SA, a clinical ... Investor Relations Michel Lussier - Interim Chief Executive Officer Charlie ...